Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

The Latest Breaking News from Clinical Trial

Novo Nordisk reveals cyberattack: Ozempic and Wegovy maker says clinical trials data breached

The company says the data is pseudonymous and apparently can't be linked to actual people.

TechRadar

Autistic children being injected with unapproved stem cell treatments supported by RFK Jr

Desperate US parents paying up to $20,000 a session for a procedure scientists say could be bogus

The Guardian - US

ZEISS announces successful early implantations of the AT LUCIA toric 721P intraocular lens

JENA, Germany, June 11, 2026 /PRNewswire/ -- ZEISS Medical Technology announced today the successful early clinical implantations of the ZEISS AT LUCIA toric 721P intraocular lens (IOL), designed to treat cataracts while simultaneously correcting astigmatism. ZEISS is currently conducting an early-access clinical trial with a select group of highly experienced…

AAP

From analysis to the latest developments in health,
read the most diverse news in one place.

Chicago's VA Hospital Just Enrolled Its First Veterans in a Psilocybin-Assisted Therapy Program — And the Science Behind Their PTSD Treatment Is Changing Psychiatry

A new VA clinical trial in Chicago is testing psilocybin-assisted therapy for treatment-resistant PTSD, offering hope to veterans.

Medical Daily

Elon Musk's biggest rival isn't a startup, it's China, and they just won the brain chip race

Elon Musk brain chip Neuralink competitor: China has approved the world's first brain-computer chip, NEO, for commercial sale after completing clinical trials. Developed by Tsinghua University and Neuracle Technology, the less invasive implant aims to aid individuals with paralysis and spinal cord injuries, marking a significant milestone ahead of Elon…

The Economic Times

Probiotic firm hopes for great things from new strain

A clinical trial is underway at La Trobe University and its Athens counterpart for an Australian-made probiotic, its owners hope will be used for inflammation.

AAP

Innovative Drug Update | Kexing Biopharm Enrolls First Subject in China-based Phase I Clinical Trial of Ophthalmic Innovative Drug GB10

SHENZHEN, China, June 4, 2026 /PRNewswire/ -- Recently, the first subject was enrolled and dosed in the Phase I clinical trial in China for GB10 Injection, an innovative ophthalmic drug independently developed by Shenzhen Kexing Pharmaceutical Co., Ltd. ("Shenzhen Kexing"), a wholly-owned subsidiary of Kexing Biopharm. Designed to treat neovascular…

AAP

Read news from The Economist, FT, and more,
with one subscription

Scientists raise alarm about effects of commonly prescribed sleeping pill

Low-dose quetiapine improves sleep quality but significantly impairs next-day alertness and driving performance, new clinical trial finds

The Independent UK

Serum Institute of India to manufacture Oxford Ebola vaccine backed by $8.6 million CEPI funding

Serum Institute of India will produce clinical trial doses of a new Ebola vaccine from Oxford University. This initiative is backed by fresh funding to combat a spreading outbreak in Africa. The vaccine uses technology similar to the Oxford-AstraZeneca Covid-19 vaccine. This partnership aims to accelerate development and ensure access…

The Economic Times

Yoga can reduce anxiety and insomnia for people living with cancer, study finds

First clinical trial of its kind, involving 410 cancer survivors in US, also finds reductions in distress and fatigue

The Guardian - UK

New cancer jab returns ‘unprecedented’ results in major clinical trial

IN FULL

The Independent UK

How a remarkable trial on bedrest during the Korean war helped lead to evidence-based medicine

In 1959, a young doctor named David Sackett stumbled on a clinical trial that would change his life – and most of ours. The study showed that conventional wisdom on bed rest in medicine was wrong. And it helped lead Sackett and others to develop evidence-based medicine, in which doctors…

The Conversation

GLP-1 Drugs Could Soon Treat Heart Failure and Peripheral Artery Disease—FDA Approvals Coming

GLP-1 drugs are no longer just weight-loss and diabetes medications. Researchers are now studying whether these blockbuster treatments can help people living with heart failure and peripheral artery disease (PAD), two serious conditions affecting millions of Americans. That shift could reshape how doctors manage cardiovascular disease in the coming years.…

Budget and the Bees

Continuity Biosciences Announces First-in-Human Clinical Trial of Precision Drug Delivery Platform for Pancreatic Cancer

CARY, N.C. and BRADENTON, Fla., May 20, 2026 /PRNewswire/ -- Continuity Biosciences, LLC, a clinical-stage biotechnology company advancing precision drug delivery platforms, today announced the initiation of a Phase I, first-in-human clinical trial evaluating gemcitabine delivered via its iontophoretic oncology platform (IOP) for the treatment of pancreatic cancer. The study,…

AAP

Get all your
news in one place.

100's of premium titles.
One news app.

Budget and the Bees

Can’t Stand Your CPAP? New Pill Slashes Sleep Apnea Events by 47% in Clinical Trials — When Could It Reach Patients?

Millions of people with obstructive sleep apnea know the nightly struggle of wearing a CPAP mask. While continuous positive airway pressure remains the gold standard treatment, many patients stop using it because of discomfort, dry mouth, noise, or claustrophobia. Now, a new sleep apnea pill called sulthiame is drawing attention…

AAP

Risen Pharma Announces Initiation of Phase 2 Clinical Trial of RP902 for Mild Cognitive Impairment Due to Alzheimer’s Disease

SHANGHAI, May 19, 2026 (GLOBE NEWSWIRE) -- Risen Pharma, a clinical-stage biotech company focusing on the development and commercialization of high-need, patient-accessible therapeutics, today announced the initiation of a Phase 2 clinical study in China of RP902, an oral small-molecule drug developed to address significant unmet medical needs in patients…

Budget and the Bees

A 4-Week Diabetes Miracle? All 10 Patients in a Chicago Trial Achieved Insulin Independence — Could This Cure Be Coming Soon

For millions of Americans living with Type 1 diabetes, every day revolves around insulin shots, glucose monitors, meal planning, and the constant fear of dangerous blood sugar swings. That is why a small but groundbreaking clinical trial in Chicago is creating massive buzz in the medical world. Researchers reported that…

MarketBeat

4D Molecular Therapeutics Touts Rapid Phase 3 Momentum for Retinal Gene Therapy

4D Molecular Therapeutics (NASDAQ:FDMT) executives said the company is seeing strong clinical trial momentum for its lead retinal gene therapy candidate, 4D-150, as it advances through late-stage development for wet age-related macular degeneration and prepares to begin a Phase 3 trial in diabetic m

Get all your
news in one place.

100's of premium titles.
One news app.

The Conversation

Clinical trials that are actually marketing ploys targeting doctors – how seeding trials put profit over patients

Some clinical trials aren’t designed to answer scientific questions. They’re designed to market drugs. In our recently published research, my team and I analyzed over 34,000 industry-funded trials and found that hundreds of studies across seven medical fields were likely designed to promote a drug to physicians rather than to…

The Conversation

The bias in medical research: Africa carries a huge disease burden but is missing from clinical trials

Modern medicine prides itself on being a universal science, built on evidence from clinical trials.

The Guardian - AU

Sam Neill announces he is cancer-free after taking part in Australian clinical trial: ‘I’m very, very excited’

Jurassic Park actor is advocating for CAR T-cell therapy, which he underwent as part of a clinical trial, to be rolled out for blood cancer patients across Australia

International Business Times

Nektar Therapeutics Stock Rockets 19% on Strong 52-Week Alopecia Areata Data for Lead Drug Candidate

Shares of Nektar Therapeutics surged more than 19% in early Monday trading on April 20, 2026, climbing $16.58 to $101.44 as investors cheered positive 52-week topline results from the Phase 2b REZOLVE-AA clinical trial of the company's lead immunology candidate, rezpegaldesleukin, in patients with severe-to-very-severe alopecia areata.

Newslaundry

India wants 1,000 new clinical trial sites. Patients are still being left in the dark

Thirty-five-year-old Ritu Bhalla was twice diagnosed with blood cancer, at the ages of four and 11. She developed chronic hepatitis B as a long-term side-effect after cancer treatment.

The Texas Tribune

Texas will launch its own clinical trials into ibogaine psychedelic after failing to find a drug company to help

The state’s effort will get a boost from the federal government thanks to a new executive order from President Donald Trump.

The Independent UK

‘We have six months to save our daughter’s life before childhood dementia robs her of her future’

Family of two-year-old face the ultimate ‘race against time’ as they fight to access life-saving treatment before it is too late

1 2 3 4 5

People

Katharine Neill Harris

13 stories

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.